INNT
TOTAL INVALIDATION PROCESSED BY THE IB
29/09/2024
Voltar para busca
Dado oficial do USPTO
BRAINEVER
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BRAINEVER
ST13
US500000079188386Classe
5, 10, 42, 44
Pedido
79188386
Registro
5220280
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
29/09/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 42, 44
Data de depósito
12/02/2016
Data de registro
13/06/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
29/12/2023
Última transação
29/12/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
PARIS, FR
Examinador
GUTTADAURO, JULIE MARIE
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
BRAINEVER
Representantes
Jeannine A Rittenhouse IpHorgan Ltd.
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical products for the protectionthe treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilitiespharmaceutical compositions for the treatment of brain and spinal cord diseases or degenerative disorders; pharmaceutical products for the treatment of all cognitive deficiencies and neurodegenerative diseases; sanitary products for medical purposesnamely for the treatment of all cognitive deficienciesneurodegenerative diseasesbrain and spinal cord diseases or degenerative disorders and for improving neurological abilities; chemo-pharmaceutical products for the treatment of all cognitive deficienciesneurodegenerative diseasesbrain and spinal cord diseases or degenerative disorders and for improving neurological abilities; biological preparations for medical usenamely for the treatment of all cognitive deficienciesneurodegenerative diseasesbrain and spinal cord diseases or degenerative disorders and for improving neurological abilities; chemical preparations for medical or pharmaceutical usenamely for the treatment of all cognitive deficienciesneurodegenerative diseasesbrain and spinal cord diseases or degenerative disorders and for improving neurological abilities; diagnostic products for medical usenamely for the treatment of all cognitive deficienciesneurodegenerative diseasesbrain and spinal cord diseases or degenerative disorders and for improving neurological abilities; medicines for human medicine for the treatment of all cognitive deficienciesneurodegenerative diseasesbrain and spinal cord diseases or degenerative disorders and for improving neurological abilities
Classe 10
Surgicalmedical apparatus and instruments for the preventiontreatment and repair of neurodegenerative diseases; testing apparatus used for the treatment of all cognitive deficiencies and neurodegenerative diseases and for the treatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities
Classe 42
Research and development of pharmaceutical products; biotechnology research and development; scientific and technological services as well as research and design services relating to the development of treatments for neurodegenerative diseases; biological research in the field of the treatment of all cognitive deficiencies and neurodegenerative diseasesthe treatment of brain and spinal cord diseases or degenerative disordersbacteriological research in the field of the treatment of all cognitive deficiencies and neurodegenerative diseasesthe treatment of brain and spinal cord diseases or degenerative disorderschemical research in the field of the treatment of all cognitive deficiencies and neurodegenerative diseasesthe treatment of brain and spinal cord diseases or degenerative disorders; medical and parapharmaceutical research in the field of the treatment of all cognitive deficiencies and neurodegenerative diseasesthe treatment of brain and spinal cord diseases or degenerative disorders; laboratory services and scientific research services particularly in the field of genetics; medical research in the field of brain diseases; technical information services relating to medicalpharmaceuticalparapharmaceutical and surgical activities; genetic research services; planning and development (design) of technical projects in the field of genetics; research and development in the field of medicine and genetics; scientific research and development services for the protectiontreatment of brain and spinal cord diseases or degenerative disorders and for improving neurological abilities; design and development of procedures and techniques for the treatment of brain and spinal cord diseases and for improving neurological abilities; clinical trials of treatments for neurodegenerative diseasesbrain or spinal cord diseasescognitive deficiencies and degenerative disorders and of diagnostic methods in the field of these diseases and genetics
Classe 44
Medical care services for neurodegenerative diseases; medical care for the treatment of brain diseases; surgical treatments of the brain and spinal cord; therapy services; diagnosing and evaluating individuals with Alzheimer's disease or any other cognitive deficiency
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
06/09/2024
INPC
INVALIDATION PROCESSED
06/09/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
30/08/2024
C71T
CANCELLED SECTION 71
29/12/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
13/06/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
28/10/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
21/09/2017
FIMP
FINAL DISPOSITION PROCESSED
21/09/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/09/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
13/06/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/03/2017
PUBO
PUBLISHED FOR OPPOSITION
28/03/2017
GPNX
NOTIFICATION PROCESSED BY IB
25/03/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/03/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/03/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/03/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
21/02/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/02/2017
DOCK
ASSIGNED TO EXAMINER
02/02/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/01/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/01/2017
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
31/01/2017
ALIE
ASSIGNED TO LIE
27/01/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/01/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/01/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/01/2017
RFNT
REFUSAL PROCESSED BY IB
29/07/2016
MAFR
APPLICATION FILING RECEIPT MAILED
12/07/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/07/2016
RFRR
REFUSAL PROCESSED BY MPU
11/07/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/07/2016
CNRT
NON-FINAL ACTION WRITTEN
08/07/2016
DOCK
ASSIGNED TO EXAMINER
08/07/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/07/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
07/07/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BRAINEVER ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.